Q1 2017 Holdings
Filed 2017-05-11 | 112 holdings | $55.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COM | 09062X103 | $20.5M | 75,000 | 37.0% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $7.2M | 255,455 | 12.9% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $5.8M | 279,166 | 10.5% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $4.4M | 345,000 | 7.9% |
| Charter Communications Inc N(CHTR) | CL A | 16119P108 | $3.9M | 11,960 | 7.1% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $3.8M | 159,664 | 6.9% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $3.3M | 668,500 | 6.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $2.6M | 150,000 | 4.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $2.0M | 152,200 | 3.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $1.6M | 401,000 | 2.8% |
| Spdr Series TrustPut | PUT | 78464A950 | $57.2K | 8,000 | 0.1% |
| Celgene Corp(CELG) | COM | 151020104 | $31.1K | 250,000 | 0.1% |
| Spdr S&P 500 ETF TRPut | PUT | 78462F953 | $23.8K | 1,000 | 0.0% |
| Novartis A G(NVSN) | SPONSORED ADR | 66987V109 | $19.0K | 255,000 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $18.7K | 295,000 | 0.0% |
| Shire PLC | SPONSORED ADR | 82481R106 | $15.4K | 214,539 | 0.0% |
| Celgene CorpCall | CALL | 151020904 | $14.9K | 1,200 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $14.3K | 483,047 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $13.3K | 390,000 | 0.0% |
| Ituran Location and Control(ITRN) | SHS | M6158M104 | $8.7K | 281,356 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $8.2K | 150,000 | 0.0% |
| Neurocrine Biosciences IncPut | PUT | 64125C959 | $8.0K | 1,500 | 0.0% |
| Horizon Pharma PLC | SHS | G4617B105 | $7.1K | 480,000 | 0.0% |
| Ishares TRPut | PUT | 464287955 | $7.0K | 500 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $6.5K | 150,000 | 0.0% |
| Versartis Inc | COM | 92529L102 | $6.4K | 300,000 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $6.3K | 700,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $6.1K | 950,000 | 0.0% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADR | 881624209 | $5.5K | 172,000 | 0.0% |
| Orbotech LTD | ORD | M75253100 | $5.1K | 157,096 | 0.0% |
| Achaogen Inc | COM | 004449104 | $5.0K | 200,000 | 0.0% |
| Teva Pharmaceutical Inds LTDCall | CALL | 881624909 | $4.7K | 1,500 | 0.0% |
| Visa Inc(V) | COM CL A | 92826C839 | $4.7K | 52,951 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $4.4K | 385,301 | 0.0% |
| Nice LTD(NSY) | SPONSORED ADR | 653656108 | $4.3K | 63,520 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $4.2K | 775,796 | 0.0% |
| Therapeuticsmd Inc | COM | 88338N107 | $4.2K | 580,000 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $4.1K | 165,700 | 0.0% |
| Genocea Biosciences Inc | COM | 372427104 | $3.9K | 646,273 | 0.0% |
| Retrophin Inc | COM | 761299106 | $3.9K | 209,131 | 0.0% |
| Teva Pharmaceutical FIN LLC | DBCV 0.250% 2/0 | 88163VAE9 | $3.8K | 6,585 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $3.8K | 250,000 | 0.0% |
| Alphabet Inc(GOOGL) | CAP STK CL A | 02079K305 | $3.7K | 4,346 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $3.6K | 500,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $3.6K | 50,000 | 0.0% |
| Avexis Inc | COM | 05366U100 | $3.4K | 45,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $3.4K | 195,500 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $3.3K | 110,000 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $3.3K | 228,534 | 0.0% |
| Caesarstone LTD(CSTE) | ORD SHS | M20598104 | $3.3K | 89,974 | 0.0% |